Skip to main content
45°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Artelo Biosciences Inc
(NQ:
ARTL
)
1.130
UNCHANGED
Streaming Delayed Price
Updated: 3:02 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.130
Bid (Size)
1.070 (1)
Ask (Size)
1.330 (1)
Prev. Close
1.130
Today's Range
1.130 - 1.130
52wk Range
1.000 - 1.750
Shares Outstanding
3,227,700
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024
August 13, 2024
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q1 2024
May 13, 2024
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
-18.12%
-18.12%
1 Month
-7.38%
-7.38%
3 Month
-9.60%
-9.60%
6 Month
-25.17%
-25.17%
1 Year
-7.09%
-7.09%
More News
Read More
ARTL Stock Earnings: Artelo Biosciences Misses EPS for Q4 2023
March 25, 2024
Via
InvestorPlace
Recap: Artelo Biosciences Q4 Earnings
March 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 06, 2024
Via
Benzinga
Recap: Artelo Biosciences Q3 Earnings
November 13, 2023
Via
Benzinga
Artelo Q2 Net Loss Declines 33% YoY, Here Is What You Need To Know
August 10, 2023
Via
Benzinga
Artelo Biosciences: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 13, 2023
Via
Benzinga
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 07, 2023
Via
Benzinga
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
September 07, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 07, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 06, 2023
Via
Benzinga
Five Studies Point To Effectiveness Of Artelo Biosciences' CBD Drug Candidate For Cancer Pain – FDA IND Application The Next Step
July 13, 2023
Via
Benzinga
Artelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain
June 27, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Artelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In Canada
June 26, 2023
Via
Benzinga
Marijuana Stock Movers For August 15, 2023
August 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Friday's Intraday Session
April 28, 2023
Via
Benzinga
Cannabis Stock Movers For July 24, 2023
July 24, 2023
Via
Benzinga
Artelo Enters Next Phase Of Evaluation Of Its Cannabinoid Receptor Targeting Drug For The Treatment Of Cancer-Related Anorexia And Weight Loss
April 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 17, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.